TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS revenue breakdown overview

TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS revenue for the last year amounted to 15.85 B USD, the most of which — 15.85 B USD — came from its highest performing source at the moment, Generics, Innovative Medicines and Over-the-counter Products, the year earlier bringing 14.93 B USD. The greatest contribution to the revenue figure was made by North America — last year it brought TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS 8.12 B USD, and the year before that — 7.45 B USD.